Sign Up Today and Learn More About Celldom, Inc Stock
Invest in or calculate the value of your shares in Celldom, Inc or other pre-IPO companies through EquityZen's platform.
Celldom, Inc Stock (CEIN)
Find and study cells that make diseases incurable
About Celldom, Inc Stock
Founded
2016
Headquarters
Durham, NC, US
Industries
Science and Engineering, Health Care, Biotechnology
Celldom is developing next generation, high throughput single cell analysis technology to advance research, drug discovery, and drug development by illuminating diversity in cell populations. The company’s TrapTx Analyzer System uniquely integrates both phenotypic and genomic data at massive scale (up to tens of thousands of cells per experiment) to identify and characterize rare cells that play critical roles in biological pathways and disease. Celldom is developing initial applications of the platform in the areas of oncology, immunology and stem cell biology.
Celldom, Inc Press Mentions
Stay in the know about the latest news on Celldom, Inc
Fluorescent barcoding of microparticles
patents • Apr 02, 2025
Sealed microwell assay
patents • Feb 13, 2025
Fluorescent barcoding of microparticles
patents • Feb 13, 2025
Celldom, Inc Management
Leadership team at Celldom, Inc
Commercial Advisor
J. Kurt Jacobus
Scientific & Commercial Advisor
Myla Lai-Goldman
Join now and verify your accreditation status to gain access to:
- Celldom, Inc Current Valuation
- Celldom, Inc Stock Price
- Celldom, Inc Management
- Available deals in Celldom, Inc and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Celldom, Inc Cap Table and Funding History by Share Class and Liquidity Preferences
- Celldom, Inc Revenue and Financials
- Celldom, Inc Highlights
- Celldom, Inc Business Model
- Celldom, Inc Risk Factors
- Celldom, Inc Research Report from SACRA Research
Trading Celldom, Inc Stock
How to invest in Celldom, Inc stock?
Accredited investors can buy pre-IPO stock in companies like Celldom, Inc through EquityZen funds. These investments are made available by existing Celldom, Inc shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Celldom, Inc stock?
Shareholders can sell their Celldom, Inc stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
